Commentary on COVID-19 Vaccine Hesitancy in sub-Saharan Africa
Severin Kabakama,Eveline T. Konje,Jerome Nyhalah Dinga,Colman Kishamawe,Imran Morhason-Bello,Peter Hayombe,Olufela Adeyemi,Ernest Chimuka,Ivan Lumu,John Amuasi,Theophilus Acheampong,Tafadzwa Dzinamarira
DOI: https://doi.org/10.3390/tropicalmed7070130
2022-07-11
Tropical Medicine and Infectious Disease
Abstract:Rates of vaccination against COVID-19 remain lower in sub-Saharan Africa than in other low and middle-income regions. This is, in part, attributed to vaccine hesitancy, mainly due to misinformation about vaccine origin, efficacy and safety. From August to December 2021, we gathered the latest experiences and opinions on four vaccine hesitancy-related areas (policies, perceived risk religious beliefs, and misinformation) from 12 sub-Saharan African researchers, four of whom have published about COVID-19 vaccine hesitancy. The authors included two political and business experts, six public health specialists, five epidemiologists, and four biostatisticians from ten sub-Saharan African countries( Cameroon, Ghana, Kenya, Liberia, Nigeria, Sierra Leone, South Africa, Tanzania, Uganda, and Zimbabwe). The authors’ overarching opinions were that political influences, religious beliefs and low perceived risk exists in sub-Saharan Africa, and they collectively contribute to COVID-19 vaccine hesitancy. Communication strategies should target populations initially thought by policy makers to be at low risk, use multiple communication avenues and address major concerns in the population.